BLES

Product Overview

About BLES

BLES is a medication containing the active ingredients Phospholipid, Surfactant-Associated Proteins SP-B, and SP-C. It is used to treat respiratory distress syndrome (RDS) in premature infants, helping to maintain lung function and facilitate breathing.

Key Benefits & Uses

• Treatment of respiratory distress syndrome (RDS) in premature infants
• Supports lung function and facilitates breathing in newborns
• Helps to reduce the risk of complications associated with RDS

Active Ingredient & Action

The active ingredients in BLES, Phospholipid, Surfactant-Associated Proteins SP-B, and SP-C, work together to reduce surface tension in the lungs, making it easier for premature infants to breathe. Phospholipid is a key component of pulmonary surfactant, which helps to maintain lung function and prevent the collapse of alveoli.

Important Notes

BLES should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions to ensure the safe and effective treatment of RDS in premature infants. As with any medication, potential side effects and interactions should be carefully evaluated before use.